Leila Hosseini

, Seyed Mehdi Vatandoust, Narmin Farazi, Amir Pasokh, Saeed Sadigh-Eteghad, Mohammad Farzipour, Fereshteh Farajdokht, Alireza Mohajjel Nayebi, Ali Hassanzadeh, Javad Mahmoudi
1 Research Center of Psychiatry and Behavioral Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
2 Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
3 University of Vienna, Department of Pharmaceutical Sciences, Division of Pharmacology and Toxicology, Vienna, Austria
4 Vienna Doctoral School of Pharmaceutical, Nutritional and Sport Sciences, University of Vienna, Josef-Holaubek-Platz 2, 1090, Vienna, Austria
5 Physical Medicine and Rehabilitation Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
6 Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
7 Department of Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
8 Medical Philosophy and History Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Abstract
Purpose: Oxidative stress, edema, and blood-brain barrier (BBB) dysfunction are involved in the pathophysiology of stroke and may offer opportunities for managing its related insults. Sericin (Ser) has neuroprotective and pro-cognitive effects. This study aimed to determine whether Ser could reduce cerebral edema and its associated molecular and cognitive abnormalities in a mouse model of cortical ischemia. Methods:The mice were allocated into five cohorts: Sham, normal saline (NS), Ser200, Ser300, and Ser400. Each group received its treatment for 14 days before being subjected to cerebral ischemia or a sham surgery procedure. Spatial memory was assessed using the Lashley III maze. Brain edema, BBB permeability, malondialdehyde (MDA) level, and changes in anti-oxidant markers (total antioxidant capacity (TAC) levels, as well as superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities) were evaluated in the brain samples. Additionally, the expression of BBB structural integrity proteins, including occludin and zonula occludens-1 (ZO-1), and matrix metalloproteinase-9 (MMP-9), were analyzed. Results: Ser300 and Ser400 improved spatial memory (at least p< 0.05). Also, Ser400 reduced brain water content (p< 0.05), Ser300 and 400 decresed BBB leakage (at least p< 0.05), and normalized anti-oxidant markers (at least p< 0.05). As well, Ser400 diminished MDA content (p< 0.05). All doses decreased MMP-9 levels (at least p< 0.01). Ser400 upregulated the expression of occludin (p< 0.01), and Ser300 and 400 increased ZO-1 proteins (at least p< 0.05). Conclusion: Ser improved cognitive dysfunction associated with BBB damage and edema induced by cerebral ischemia in a mouse model.